Join
Live feed
·
PRReleasevia Quantisnow
Guardant Health Inc. logo
Nuvalent Inc. logo

Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GH (Guardant Health Inc.), NUVL (Nuvalent Inc.) and more on Quantisnow.